BCL2 and prostate adenocarcinoma: In addition, other studies have found that low expression of PYGB in PRAD can regulate the expression of CASP3 and Bcl-2, upregulate ROS content, regulate the Nrf2 signalling pathway, and accelerate apoptosis of PC3 cells [24].